Stryker neurovascular devices recalled for inadequate endotoxin testing
Stryker Neurovascular is recalling Trevo ProVue devices due to manufacturing testing deficiency that may result in unsafe endotoxin levels and risk of fever, shock, or aseptic meningitis.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall involving a manufacturing compliance deficiency. While the potential harms—fever, shock, and aseptic meningitis—are serious, no illnesses or hospitalizations are reported and the contamination risk is theoretical based on the 'may exceed' language in the source.
Plain-English summary
Stryker Neurovascular is recalling 280 Trevo ProVue neurovascular devices (Catalog 90184) with Lot Numbers 118117, 118420, and 118833.
During manufacturing, these devices did not meet the minimum sample size required for endotoxin testing and are out of compliance with the AAMI ST72 standard. As a result, the devices may exceed the acceptable limits of endotoxin levels.
High levels of endotoxins may increase the risk of fever, shock, and aseptic meningitis. The FDA has classified this as a Class II recall.
The recalled devices were distributed worldwide and throughout the United States. If you have received these devices, contact your healthcare provider or Stryker Neurovascular for guidance.
The recalled product
- Product
- Trevo ProVue, Catalog: 90184
- Manufacturer
- Stryker Neurovascular
- Category
- Medical Device — Neurovascular
- Affected units
- 280
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Catalog: 90184
- UDI-DI: 00815742001846
- Lot: 118117
- 118420
- 118833
Distribution
Part of a larger recall action
This product is one of 8 recalled by Stryker Neurovascular under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 8 products in this recall →Related recalls
Same manufacturer · Stryker Neurovascular
See all →- HighStryker Neurovascular INZONE Detachment System battery drain
FDA (Devices) · 2026-07-01
- HighTrevo Trak 21 Microcatheter Distributed with Incorrect Instructions and Labels
FDA (Devices) · 2024-10-16
- HighSynchro2 Guidewires: PTFE coating damage from improper backloading technique
FDA (Devices) · 2024-06-12
- HighSynchro SELECT Guidewires may have PTFE coating damage
FDA (Devices) · 2024-06-12
- HighStryker Synchro Neuro Guidewires Recalled for PTFE Coating Damage Risk
FDA (Devices) · 2024-06-12
Same hazard · endotoxin
See all →- HighNipro MedicaLyte Bicarbonate Powder Recalled for High Endotoxin Levels
FDA (Devices) · 2026-09-16
- SevereNipro Citric Complete Dry Citric Acid Concentrate Recalled for High Endotoxin Levels
FDA (Devices) · 2026-09-16
- SevereMedicaLyte Liquid Bicarbonate Concentrate Recalled for High Endotoxin Levels
FDA (Devices) · 2026-09-16
- SevereNipro Citric Complete Liquid Citric Acid Concentrate Recalled for High Endotoxin Levels
FDA (Devices) · 2026-09-16
- HighMedline Medical Convenience Kits Recalled for Endotoxin Levels
FDA (Devices) · 2026-09-02